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Abstract: Postpartum thyroiditis occurs in women after delivery and can cause both thyrotoxicosis and hypothyroidism. 
We report the case of a 29 years old female patient who presented with dyspnea, ascites and asthenia two months after delivery. It was a heart 
failure with a reduced left ventricular ejection fraction (LVEF = 36%) and a mild systolic pulmonary artery hypertension (sPAP = 37,3 mmHg) 
contrasting with very significant and persistent congestive signs in spite of diuretic treatment. Cardiovascular risk was low. The thyroid tests 
showed hypothyroidism (TSH = 8,1 mUI/l, T4L = 2,9 pmol/l). Improvement in general condition of the patient and congestive signs were 
obtained five days after a levothyroxine therapy.  
Thyroid biological test should be part of the etiological research of heart failure in the peripartum period, especially when the patient’s 
cardiovascular risk is low. 
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INTRODUCTION 
Postpartum thyroiditis (PTT) is thyroiditis that occurs in 
women after delivery and can cause both thyrotoxicosis and 
hypothyroidism (1). In postpartum thyroiditis, thyrotoxicosis 
occurs first (two months postpartum) followed by 
hypothyroidism (third up to sixth month in postpartum) (1). 
It typically happens during the first year following childbirth 
(1). Thyroid hormone has a great effect on the heart and 
vascular system (2). The heart is sensitive to changes in 
thyroid hormones and cardiac disorders are commonly 
associated with both hyper- and hypothyroidism (3-4). 
Dilated cardiomyopathy is a rare presentation of 
hypothyroidism (5). 
 
Our goal was to report a cardiomyopathy due to 
hypothyroidism in the post-partum period. 
CASE PRESENTATION  
We report a case of a 29 years old female patient 
(Pregnancy=3, Parity=3, Abortion=0, who presented with an 
abdominal distension, a difficulty in breathing and asthenia 
two months after delivery. 
 
The abdominal distension progressively increased with 
lower limbs swelling. Difficulty in breathing was of gradual 
onset, progressively increasing in severity, initially on 
exertion, later even at rest requiring the use of up to 2 
pillows while sleeping with occasional nocturnal dry cough. 
There was no chest pain or history of fever. The patient 
didn’t have hypertension or pregnancy induced 
hypertension. She was not diabetic and had no history of 
cardiopathy. There was no difficulty or hemorrhage during 
delivery. 
 
On day of admission, the patient was orthopneic, respiratory 
rate was 28 breaths/min, oxygen saturation was 98% with 
bilateral bibasal crepitations. The blood pressure was 
109/67mmHg. Cardiac auscultation found a heart rate of 107 
beats/min, a B3 sound, a grade 3 pansystolic murmur 
radiating to axilla suggesting a mitral regurgitation and a 
tricuspid regurgitation murmur. The patient presented with 
ascites, infiltration of abdominal subcutaneous tissues and a 
severe edema of the lower limbs up to the root of the thighs. 
There was no axillary or pubis depilation. 
 
Blood investigations showed the following results: white 
blood cells (K/UL): 6.6, hemoglobin (g/dl): 9.4, platelets 
(K/UL): 229, albumin (g/L): 32, Na+ (mmol/l): 132, K+ 
(mmol/l): 3.9, Cl- (mmol/l): 93, creatinine (µmol/l): 98, 
eGFR 65mls/min. Chest x-ray showed cardiomegaly without 
any image of pneumopathy. Twelve-lead ECG showed sinus 
tachycardia (110 beats/min), low voltage on frontal 
derivations and planed R wave from V1 to V3. 
Echocardiography showed a dilated left ventricle (57 mm in 
telediastole), a dilated left atrium (28 cm
2
), a global 
hypokinesia with ejection fraction of 36% (Simpson 
biplane). Left ventricular filling pressures was high (E/Ea = 
16,5). There was a mild systolic pulmonary arterial 
hypertension (sPAP = 37,3 mmHg) and a moderate 
pericardial effusion. 
 
Initial diagnosis was a NYHA IV acute decompensated 
heart failure secondary to a peripartum cardiomyopathy. The 
patient was treated with intravenous furosemide 200 mg 
daily, ramipril 2,5 mg twice daily, carvedilol 3,125 mg daily 
and potassium supplementation. With this treatment, 
respiratory status improved but peripheral congestive signs 
persisted with unsatisfactory weight loss although renal 
function was correct.  
 
We suspected an associated myxedema because of the 
severe and diuretic-resistant edemas contrasting with a mild 
pulmonary arterial hypertension. Thyroid investigations 
showed an increase of the thyroid stimulating hormone or 
TSH (8,1 mUI/l for a normal range of 0,3 - 4,5 mUI/l) and a 
decrease of free thyroxine (2,9 pmol/l for a normal range of 
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8,6 - 25 pmol/l). Ultrasound showed a normal sized but 
hypoechogene thyroid.  A.M. plasma cortisol was checked 
to assess other pituitary hormone lines and it was normal. 
Hormone replacement therapy was started with 
levothyroxine 100 µg tablet a day. Then oedematous 
syndrome markedly decreased and the general condition of 
the patient greatly improved five days later. 
DISCUSSION 
PTT is an autoimmune disease, characterized by the 
presence of antimicrosomal antibodies according to Neal 
DM et al. Histologic examination of PTT-affected thyroid 
glands reveals destructive lymphocytic thyroiditis (6). 
 
Thyroid hormones act on cardiac myocytes and peripheral 
vasculature. The genomic and non-genomic effects of 
thyroid hormone are related to the cardiac function and 
cadiovascular hemodynamics (4). To explain their possible 
genomic effects on the cardiovascular system, it has been 
proposed that thyroid hormone is involved in the regulation 
of the messenger ribonucleic acids (mRNA) transcription of 
genes associated with the contractile system (2). They have 
a non-genomic effects on the ionic channels of 
cardiomyocyte's membrane (4). So, apart from 
autoimmunity mechanism, hypothyroidism is associated 
with decreased cardiac contractility, increased systemic 
vascular resistance and decreased cardiac output (7). 
Moreover, patients with hypothyroidism are at increased 
risks of developing atherosclerosis and ischemic heart 
disease (8-9). It has been reported that the cardiac 
manifestations are associated with alterations in the 
expression of T3-mediated genes in patients with thyroid 
dysfunction (4-10). According to Curotto et al, patients with 
chronic heart failure and hypothyroidism significantly 
improve their physical performance when normal TSH 
levels were reached (11). 
 
The main differential diagnosis in this situation is Sheehan 
syndrome which is due to a panhypopitutarism following a 
postpartum hemorrhage (12). The cause of this 
panhypopitutarism is thought to be ischemic necrosis of the 
anterior pituitary secondary to postpartum hemorrhage (12). 
Cardiac abnormalities have been reported in patients with 
hypopituitarism, most of these being linked to growth 
hormone deficiency, hypothyroidism and/or hypocortisol 
state (13-14). That syndrom is rare but should be sought 
(12). In our case, the absence of postpartum hemorrhage, the 
presence of axillary and pubic hair and the normality of 
other pituitary hormone especially the cortisol were against 
that diagnosis.  
CONCLUSION 
Our case highlights that clinicians should consider the 
possibility of hypothyroidism as a cause of dilated 
cardiomyopathy in the postpartum period, when edematous 
syndrome is resistant to diuretics, especially when the 
patient’s cardiovascular risk is low. Peri-partum 
cardiomyopathy is a diagnosis of exclusion. 
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